

  • Đời sống
    • Du lịch
    • Ăn chơi
    • Làm vườn
  • Giải trí
  • Giáo dục
  • Kinh doanh
    • Thương mại điện tử
    • Bất động sản
    • Globe Newswire
  • Sức khỏe
    • Dinh dưỡng
    • Làm đẹp
  • Khoa học
  • Công Nghệ
  •  Tài khoản
  • ĐĂNG NHẬP TÀI KHOẢN

    
    Hoặc
  • 


  •  Trang chủ
  •  Mới nhất
  •  TOP 10 
    • TOP 2018
    • TOP 2015
    • TOP 2014
  • Facebook
CDT Environmental Technology Investment Holdings Limited Files Annual Report on Form 20-F 21-05-2024, 07:00
Meltwater announces new partnership with digital agency dig.human 4-04-2024, 23:00
BitMEX Study Reveals Superior Performance of Perpetual Swap Listings, with an Average Price Gain of 62.55%, Outperforming Competitors 7-04-2025, 20:02
 3-10-2024, 22:18

Dark Horse Consulting Group Acquires BioTechLogic, Inc.

Globe Newswire3-10-2024, 22:18
 18-09-2024, 22:07

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brai

Globe Newswire18-09-2024, 22:07
 3-09-2024, 20:25

Music Licensing, Inc. (OTC: SONG) Announces Acquisition of Royalty Rights to "Thank God I Got It" by Desiigner, Bolstering Its Diverse and Star-Studded Portfolio

Globe Newswire3-09-2024, 20:25
 22-08-2024, 03:15

Olaplex Holdings, Inc. Announces Participation in the Barclays 17th Annual Global Consumer Staples Conference on September 4th

Globe Newswire22-08-2024, 03:15
 15-08-2024, 20:47

Matmerize, Inc., Introduces “ASKPOLY” – A Language Model Based Polymer Expert

Globe Newswire15-08-2024, 20:47
 16-07-2024, 20:26

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis

Globe Newswire16-07-2024, 20:26
 10-07-2024, 07:00

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal

Globe Newswire10-07-2024, 07:00
 9-07-2024, 07:00

Io Therapeutics, Inc., announces presentation of data on induction of tumor growth inhibiting anti-cancer immune responses in multiple types of cancers by a IRX5010, a novel retinoic acid nuclear receptor agonist compound

Globe Newswire9-07-2024, 07:00
 28-05-2024, 20:00

Music Licensing, Inc. (OTC: SONGD) Acquires Prestigious Royalty-Generating IP Stake in "Goodnight Gotham" by Rihanna

Globe Newswire28-05-2024, 20:00
 20-05-2024, 20:07

Music Licensing, Inc. (OTC: SONGD) Receives Third Royalty Payment from Stake in Listerine "Mouthwash" Antiseptic

Globe Newswire20-05-2024, 20:07
 6-05-2024, 19:15

Exodus Movement, Inc. Announces Uplist to NYSE American Exchange

Globe Newswire6-05-2024, 19:15
 4-04-2024, 20:05

Matmerize, Inc. and CJ Biomaterials Partner to Utilize Innovative AI Technology to Advance Sustainable Polymer Solutions

Globe Newswire4-04-2024, 20:05

Liên hệ quảng cáo

Hotline hỗ trợ quảng cáo: 0914.222.131
Email: quangcao@vietsoftgroup.com

Email: info@vietsoftgroup.com

© Copyright 2019 - Trang tin tức chuyên đề giới trẻ TCN News - Toàn bộ bài viết được chi sẻ bởi các thành viên.